STABLE LIQUID BORTEZOMIB FORMULATIONS
Application
US20260083760A1
Kind: A1
Mar 26, 2026
Assignee
Riconpharma LLC
Inventors
Mukteeshwar Gande, Praveen Reddy Billa, SVB Janardhan Garikipati, Vinay Sudhindra Raichur, Vijaya Kumar Thota
Abstract
Described herein are liquid compositions comprising: bortezomib; mannitol in an amount up to about 50 mg/mL; and a pharmaceutically acceptable carrier, wherein the liquid composition is for intravenous or subcutaneous use; and wherein the liquid composition comprises not more than (NMT) 1.0% of Impurity-E; Impurity-L; Impurity-J; Impurity-F; Impurity-I; or Impurity-U; and NMT than 3.0% of Total Impurities. Methods of making and using these compositions are also described herein.
CPC Classifications
A61K 31/69
A61K 9/0019
A61K 9/08
A61K 47/02
A61K 47/26
Filing Date
2025-09-26
Application No.
19341758